New insight into the role of altered brain cholesterol metabolism in the pathogenesis of AD: A unifying cholesterol hypothesis and new therapeutic approach for AD
Authors:
Open Access
- 31 March 2025
- journal article
- review article
- Published by Elsevier in Brain Research Bulletin
- Vol. 224, 111321
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Health and Medical Development Foundation (201740209)
This publication has 303 references indexed in Scilit:
- Impact of increased APP gene dose in Down syndrome and the Dp16 mouse modelAlzheimer's & Dementia, 2021
- Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse modelAlzheimer's & Dementia, 2020
- Alzheimer's amyloid‐β and tau protein accumulation is associated with decreased expression of the LDL receptor‐associated protein in human brain tissueBrain and Behavior, 2020
- Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOBJAMA Neurology, 2019
- Amyloid-β and TauJAMA Neurology, 2014
- Twenty-six–Year Change in Total Cholesterol Levels and Incident DementiaArchives of Neurology, 2007
- Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1/NPC2Annals of Neurology, 2002
- Apolipoprotein E isoforms in Alzheimer's disease pathology and etiologyMicroscopy Research and Technique, 2000
- Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesisJournal of Neuroscience Research, 1998
- Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severityAnnals of Neurology, 1990